Short-Term Pioglitazone Treatment Improves Vascular Function Irrespective of Metabolic Changes in Patients With Type 2 Diabetes
Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: pioglitazone, type 2 diabetes, endothelial dysfunction, vascular function, flow-mediated dilation, brachial artery, PPARγ agonists, insulin resistance, free fatty acids, adiponectin, C-reactive protein, low-grade inflammation, endothelium-independent relaxation, glycemic control, conduit arteries, sex differences in drug response
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W1994269792
